Acadian Asset Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-812,459
| Closed | -$1.22M | – | 1966 |
|
|
2023
Q1 | $1.22M | Sell |
812,459
-62,394
| -7% | -$93.5K | 0.01% | 830 |
|
|
2022
Q4 | $872K | Buy |
874,853
+191,739
| +28% | +$191K | ﹤0.01% | 882 |
|
|
2022
Q3 | $1.23M | Buy |
683,114
+141,239
| +26% | +$254K | 0.01% | 752 |
|
|
2022
Q2 | $1.57M | Buy |
541,875
+62,357
| +13% | +$181K | 0.01% | 690 |
|
|
2022
Q1 | $1.32M | Buy |
479,518
+465,207
| +3,251% | +$1.28M | 0.01% | 771 |
|
|
2021
Q4 | $65K | Buy |
+14,311
| New | +$65K | ﹤0.01% | 1453 |
|
|
2020
Q2 | – | Sell |
-1,766
| Closed | -$14K | – | 2379 |
|
|
2020
Q1 | $14K | Buy |
+1,766
| New | +$14K | ﹤0.01% | 1689 |
|